(Q38319943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

review article

1 reference

title

Mesenchymal stem cells: a friend or foe in immune-mediated diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

main subject

mesenchymal stem cell

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

4

Miodrag Stojkovic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1

Marina Gazdic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Vladislav Volarevic

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

1 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

number of pages

8

1 reference

Stem Cell Reviews and Reports

inferred from page(s)

published in

1 reference

2 September 2017

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

280-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25592610%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12015-014-9583-3

28 February 2020

exact match

0 references

cites work

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

The immunomodulatory capacity of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Neuroepithelial cells supply an initial transient wave of MSC differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

A perivascular origin for mesenchymal stem cells in multiple human organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human stem cell research and regenerative medicine--present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Stem cell-based therapy for spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells: a double-edged sword in regulating immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cell effects on T-cell effector pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

How do mesenchymal stromal cells suppress T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stromal cells: sensors and switchers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Regulation of immune responses by prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Retracted: Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Concise review: two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cell-educated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Mesenchymal stem cells stimulate antibody secretion in human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Toll-Like Receptor-3-Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9583-3

Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation

21 January 2018

1 reference

12 December 2020

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

1 reference

12 December 2020

Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells.

1 reference

12 December 2020

Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype

1 reference

12 December 2020

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

12 December 2020

Mesenchymal stem cells suppress CD8+ T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-β

1 reference

12 December 2020

Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells

1 reference

12 December 2020

Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression

1 reference

12 December 2020

Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction

1 reference

12 December 2020

Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method

1 reference

12 December 2020

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

1 reference

12 December 2020

Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge

1 reference

12 December 2020

TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.

1 reference

12 December 2020